NO20000519D0 - 2-acylaminopropanaminer sok takykinin-reseptor-antagonister - Google Patents
2-acylaminopropanaminer sok takykinin-reseptor-antagonisterInfo
- Publication number
- NO20000519D0 NO20000519D0 NO20000519A NO20000519A NO20000519D0 NO 20000519 D0 NO20000519 D0 NO 20000519D0 NO 20000519 A NO20000519 A NO 20000519A NO 20000519 A NO20000519 A NO 20000519A NO 20000519 D0 NO20000519 D0 NO 20000519D0
- Authority
- NO
- Norway
- Prior art keywords
- acylaminopropanamines
- sock
- receptor antagonists
- tachykinin receptor
- tachykinin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5499797P | 1997-08-06 | 1997-08-06 | |
| PCT/US1998/016333 WO1999007677A1 (en) | 1997-08-06 | 1998-08-06 | 2-acylaminopropanamines as tachykinin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000519D0 true NO20000519D0 (no) | 2000-02-01 |
| NO20000519L NO20000519L (no) | 2000-03-31 |
Family
ID=21994906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000519A NO20000519L (no) | 1997-08-06 | 2000-02-01 | 2-acylaminopropanaminer som takykininreseptorantagonister |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6358994B1 (no) |
| EP (1) | EP1005454A4 (no) |
| JP (1) | JP2001512715A (no) |
| KR (1) | KR20010022581A (no) |
| CN (1) | CN1272842A (no) |
| AU (1) | AU8693398A (no) |
| BR (1) | BR9811821A (no) |
| CA (1) | CA2298701A1 (no) |
| EA (1) | EA200000198A1 (no) |
| HR (1) | HRP20000065A2 (no) |
| HU (1) | HUP0002929A3 (no) |
| ID (1) | ID24468A (no) |
| IL (1) | IL134301A0 (no) |
| NO (1) | NO20000519L (no) |
| PL (1) | PL338453A1 (no) |
| TR (1) | TR200000291T2 (no) |
| WO (1) | WO1999007677A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8692698A (en) * | 1997-08-06 | 1999-03-01 | Eli Lilly And Company | 2-acylaminopropanamines as tachykinin receptor antagonists |
| KR100599134B1 (ko) * | 2001-04-23 | 2006-07-12 | 에프. 호프만-라 로슈 아게 | 양성 전립선 비대증에 대한 ｎｋ-1 수용체 길항물질의 용도 |
| DE60321907D1 (de) * | 2002-04-26 | 2008-08-14 | Lilly Co Eli | Tachykininrezeptorantagonisten |
| MY141559A (en) | 2002-04-26 | 2010-05-14 | Lilly Co Eli | Triazole derivatives as tachykinin receptor antagonists |
| AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| CA2613068A1 (en) * | 2005-06-30 | 2007-01-11 | Smithkline Beecham Corporation | Indole carboxamides as ikk2 inhibitors |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ｉｋｋ２阻害剤としてのインドール誘導体 |
| WO2011104307A2 (en) * | 2010-02-25 | 2011-09-01 | Graffinity Pharmaceuticals Gmbh | Ligands for antibody purification by affinity chromatography |
| CN105906608B (zh) * | 2016-05-03 | 2018-10-19 | 中山大学 | 8-氨基喹啉-松果体素杂联体及其药物组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
| US5278316A (en) * | 1989-06-29 | 1994-01-11 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| EP0916346A3 (en) | 1991-09-20 | 2000-12-06 | Glaxo Group Limited | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
| US5328927A (en) | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| WO1994001402A1 (en) * | 1992-07-13 | 1994-01-20 | Merck Sharp & Dohme Limited | Heterocyclic amide derivatives as tachykinin derivatives |
| EP0655055B1 (en) | 1992-08-13 | 2000-11-29 | Warner-Lambert Company | Tachykinin antagonists |
| WO1994010167A1 (en) | 1992-10-30 | 1994-05-11 | Merck Sharp & Dohme Limited | Tachykinin antagonists |
| US6403577B1 (en) | 1993-11-17 | 2002-06-11 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| US5491140A (en) | 1994-06-30 | 1996-02-13 | Eli Lilly And Company | Naphthyl tachykinin receptor antagonists to treat physiological conditions |
| AU688072B2 (en) * | 1994-07-12 | 1998-03-05 | Eli Lilly And Company | Heterocyclic tachykinin receptor antagonists |
-
1998
- 1998-08-06 TR TR2000/00291T patent/TR200000291T2/xx unknown
- 1998-08-06 AU AU86933/98A patent/AU8693398A/en not_active Abandoned
- 1998-08-06 CA CA002298701A patent/CA2298701A1/en not_active Abandoned
- 1998-08-06 IL IL13430198A patent/IL134301A0/xx unknown
- 1998-08-06 ID IDW20000220A patent/ID24468A/id unknown
- 1998-08-06 KR KR1020007001172A patent/KR20010022581A/ko not_active Application Discontinuation
- 1998-08-06 HU HU0002929A patent/HUP0002929A3/hu unknown
- 1998-08-06 WO PCT/US1998/016333 patent/WO1999007677A1/en not_active Application Discontinuation
- 1998-08-06 JP JP2000506181A patent/JP2001512715A/ja not_active Withdrawn
- 1998-08-06 EP EP98938403A patent/EP1005454A4/en not_active Withdrawn
- 1998-08-06 BR BR9811821-8A patent/BR9811821A/pt not_active Application Discontinuation
- 1998-08-06 EA EA200000198A patent/EA200000198A1/ru unknown
- 1998-08-06 US US09/463,855 patent/US6358994B1/en not_active Expired - Fee Related
- 1998-08-06 PL PL98338453A patent/PL338453A1/xx unknown
- 1998-08-06 CN CN98809800A patent/CN1272842A/zh active Pending
-
2000
- 2000-02-01 NO NO20000519A patent/NO20000519L/no not_active Application Discontinuation
- 2000-02-04 HR HR20000065A patent/HRP20000065A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6358994B1 (en) | 2002-03-19 |
| IL134301A0 (en) | 2001-04-30 |
| HUP0002929A3 (en) | 2002-01-28 |
| EA200000198A1 (ru) | 2000-10-30 |
| EP1005454A4 (en) | 2003-01-15 |
| TR200000291T2 (tr) | 2000-07-21 |
| JP2001512715A (ja) | 2001-08-28 |
| HUP0002929A2 (hu) | 2001-10-28 |
| NO20000519L (no) | 2000-03-31 |
| BR9811821A (pt) | 2000-08-15 |
| PL338453A1 (en) | 2000-11-06 |
| CA2298701A1 (en) | 1999-02-18 |
| EP1005454A1 (en) | 2000-06-07 |
| AU8693398A (en) | 1999-03-01 |
| KR20010022581A (ko) | 2001-03-26 |
| WO1999007677A1 (en) | 1999-02-18 |
| ID24468A (id) | 2000-07-20 |
| HRP20000065A2 (en) | 2001-04-30 |
| CN1272842A (zh) | 2000-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| FI952064A0 (fi) | Takykiniinireseptoriantagonisteja, joilla ei ole peptidyylirakennetta | |
| ID19623A (id) | Antagonis reseptor vitronektin | |
| DK1009732T3 (da) | 1-Amino-alkylcyclohexan NMDA receptor antagonister | |
| ATE315035T1 (de) | Ccr-3-rezeptor-antagonisten | |
| NO20001100D0 (no) | IL-8 reseptorantagonister | |
| DE69921351D1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| NO993350D0 (no) | Vitronectin-reseptor-antagonister | |
| DE69823694T2 (de) | Thrombin-rezeptor antagonisten | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| ID26223A (id) | Antagonis reseptor vitronektin | |
| ATE286022T1 (de) | Naphthalin-carboxamide als tachykinin rezeptorantagonisten | |
| NO20000519D0 (no) | 2-acylaminopropanaminer sok takykinin-reseptor-antagonister | |
| ATE381330T1 (de) | Il-8 rezeptor-antagonisten | |
| ID28811A (id) | Antagonis reseptor vitronektin | |
| ATE303370T1 (de) | Il-8 rezeptor antagonisten | |
| ATE290546T1 (de) | Tachykinin antagoniste | |
| DE69824837D1 (de) | Il-8-rezeptor-antagonisten | |
| NO20000518D0 (no) | 2-acylaminopropanaminer sok takykinin-reseptor-antagonister | |
| ID22978A (id) | Antagonis reseptor endotelin | |
| DK0964867T3 (da) | Tachykininantagonister | |
| DE69830671D1 (de) | Integrin-rezeptor-antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |